Literature DB >> 27552145

Combining High-Content Imaging and Phenotypic Classification Analysis of Senescence-Associated Beta-Galactosidase Staining to Identify Regulators of Oncogene-Induced Senescence.

Keefe T Chan1, Lassi Paavolainen2, Katherine M Hannan3,4, Amee J George3,5, Ross D Hannan1,3,4,5,6,7, Kaylene J Simpson6,8, Peter Horvath2,9, Richard B Pearson1,4,6,7.   

Abstract

Hyperactivation of the PI3K/AKT/mTORC1 signaling pathway is a hallmark of the majority of sporadic human cancers. Paradoxically, chronic activation of this pathway in nontransformed cells promotes senescence, which acts as a significant barrier to malignant progression. Understanding how this oncogene-induced senescence is maintained in nontransformed cells and conversely how it is subverted in cancer cells will provide insight into cancer development and potentially identify novel therapeutic targets. High-throughput screening provides a powerful platform for target discovery. Here, we describe an approach to use RNAi transfection of a pre-established AKT-induced senescent cell population and subsequent high-content imaging to screen for senescence regulators. We have incorporated multiparametric readouts, including cell number, proliferation, and senescence-associated beta-galactosidase (SA-βGal) staining. Using machine learning and automated image analysis, we also describe methods to classify distinct phenotypes of cells with SA-βGal staining. These methods can be readily adaptable to high-throughput functional screens interrogating the mechanisms that maintain and prevent senescence in various contexts.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27552145     DOI: 10.1089/adt.2016.739

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  2 in total

1.  A functional genetic screen defines the AKT-induced senescence signaling network.

Authors:  Keefe T Chan; Shaun Blake; Haoran Zhu; Jian Kang; Anna S Trigos; Piyush B Madhamshettiwar; Jeannine Diesch; Lassi Paavolainen; Peter Horvath; Ross D Hannan; Amee J George; Elaine Sanij; Katherine M Hannan; Kaylene J Simpson; Richard B Pearson
Journal:  Cell Death Differ       Date:  2019-07-08       Impact factor: 15.828

2.  HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.

Authors:  Alison Howarth; Martin Schröder; Raquel C Montenegro; David H Drewry; Heba Sailem; Val Millar; Susanne Müller; Daniel V Ebner
Journal:  SLAS Discov       Date:  2020-05-27       Impact factor: 3.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.